Cargando…

Clinical aspects and treatment of hepatocellular carcinoma in north-eastern Poland

AIM OF THE STUDY: Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, with poor treatment outcomes often because of delayed diagnosis. The aim of this study was to assess the co-incidence of cirrhosis, alcohol abuse, hepatitis B virus (HBV) or hepatitis C virus (HCV) infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Łapiński, Tadeusz Wojciech, Tarasik, Aleksandr, Januszkiewicz, Marcin, Flisiak, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122092/
https://www.ncbi.nlm.nih.gov/pubmed/34027119
http://dx.doi.org/10.5114/ceh.2021.104631
_version_ 1783692513336360960
author Łapiński, Tadeusz Wojciech
Tarasik, Aleksandr
Januszkiewicz, Marcin
Flisiak, Robert
author_facet Łapiński, Tadeusz Wojciech
Tarasik, Aleksandr
Januszkiewicz, Marcin
Flisiak, Robert
author_sort Łapiński, Tadeusz Wojciech
collection PubMed
description AIM OF THE STUDY: Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, with poor treatment outcomes often because of delayed diagnosis. The aim of this study was to assess the co-incidence of cirrhosis, alcohol abuse, hepatitis B virus (HBV) or hepatitis C virus (HCV) infection and fatty liver disease in patients in the population of north-eastern Poland, to analyse the usefulness of α-fetoprotein (AFP) in the diagnosis of HCC and to assess the effectiveness of HCC treatment in this group. MATERIAL AND METHODS: The study involved 104 patients diagnosed with HCC. The age, sex, comorbidities, HCC risk factors and levels of AFP were analysed. The effect of antiviral therapy of HCV and HBV on HCC development was observed and the effectiveness of therapies used in the treatment of HCC was assessed. RESULTS: Over 90% of patients with HCC were older than 45 years. The incidence of HCC was higher in men than in women. Patients with HCC were also diagnosed with cirrhosis (72%), alcohol abuse (35%), HCV infection (35%), HBV infection (24%), and fatty liver disease (13%). HCC developed in 9/25 (36%) patients positive for HBV despite effective antiviral therapy. The highest AFP levels were found in HBV-positive patients. The mean survival time was 19 months for partial hepatectomy and 16 months for thermal ablation. CONCLUSIONS: The main predisposing factor for HCC is cirrhosis, followed by alcohol abuse and infection with HCV. Effective antiviral therapy for HBV does not prevent the development of HCC in all cases. Since 29% of patients were disqualified from HCC treatment due to an advanced stage of cancer, it indicates insufficient screening for HCC. Partial hepatectomy and radiofrequency ablation show comparable effectiveness in the treatment of HCC.
format Online
Article
Text
id pubmed-8122092
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-81220922021-05-21 Clinical aspects and treatment of hepatocellular carcinoma in north-eastern Poland Łapiński, Tadeusz Wojciech Tarasik, Aleksandr Januszkiewicz, Marcin Flisiak, Robert Clin Exp Hepatol Original Paper AIM OF THE STUDY: Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, with poor treatment outcomes often because of delayed diagnosis. The aim of this study was to assess the co-incidence of cirrhosis, alcohol abuse, hepatitis B virus (HBV) or hepatitis C virus (HCV) infection and fatty liver disease in patients in the population of north-eastern Poland, to analyse the usefulness of α-fetoprotein (AFP) in the diagnosis of HCC and to assess the effectiveness of HCC treatment in this group. MATERIAL AND METHODS: The study involved 104 patients diagnosed with HCC. The age, sex, comorbidities, HCC risk factors and levels of AFP were analysed. The effect of antiviral therapy of HCV and HBV on HCC development was observed and the effectiveness of therapies used in the treatment of HCC was assessed. RESULTS: Over 90% of patients with HCC were older than 45 years. The incidence of HCC was higher in men than in women. Patients with HCC were also diagnosed with cirrhosis (72%), alcohol abuse (35%), HCV infection (35%), HBV infection (24%), and fatty liver disease (13%). HCC developed in 9/25 (36%) patients positive for HBV despite effective antiviral therapy. The highest AFP levels were found in HBV-positive patients. The mean survival time was 19 months for partial hepatectomy and 16 months for thermal ablation. CONCLUSIONS: The main predisposing factor for HCC is cirrhosis, followed by alcohol abuse and infection with HCV. Effective antiviral therapy for HBV does not prevent the development of HCC in all cases. Since 29% of patients were disqualified from HCC treatment due to an advanced stage of cancer, it indicates insufficient screening for HCC. Partial hepatectomy and radiofrequency ablation show comparable effectiveness in the treatment of HCC. Termedia Publishing House 2021-03-25 2021-03 /pmc/articles/PMC8122092/ /pubmed/34027119 http://dx.doi.org/10.5114/ceh.2021.104631 Text en Copyright © 2021 Clinical and Experimental Hepatology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) )
spellingShingle Original Paper
Łapiński, Tadeusz Wojciech
Tarasik, Aleksandr
Januszkiewicz, Marcin
Flisiak, Robert
Clinical aspects and treatment of hepatocellular carcinoma in north-eastern Poland
title Clinical aspects and treatment of hepatocellular carcinoma in north-eastern Poland
title_full Clinical aspects and treatment of hepatocellular carcinoma in north-eastern Poland
title_fullStr Clinical aspects and treatment of hepatocellular carcinoma in north-eastern Poland
title_full_unstemmed Clinical aspects and treatment of hepatocellular carcinoma in north-eastern Poland
title_short Clinical aspects and treatment of hepatocellular carcinoma in north-eastern Poland
title_sort clinical aspects and treatment of hepatocellular carcinoma in north-eastern poland
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122092/
https://www.ncbi.nlm.nih.gov/pubmed/34027119
http://dx.doi.org/10.5114/ceh.2021.104631
work_keys_str_mv AT łapinskitadeuszwojciech clinicalaspectsandtreatmentofhepatocellularcarcinomainnortheasternpoland
AT tarasikaleksandr clinicalaspectsandtreatmentofhepatocellularcarcinomainnortheasternpoland
AT januszkiewiczmarcin clinicalaspectsandtreatmentofhepatocellularcarcinomainnortheasternpoland
AT flisiakrobert clinicalaspectsandtreatmentofhepatocellularcarcinomainnortheasternpoland